Pharmacists cannot open clinics to diagnose disease & prescribe medicine; clarifies PCI

Clearing the doubts on pharmacists can open pharma clinics to treat common disease and prescribe medicine, Pharmacy Council of India (PCI) has recently notified that the pharmacists cannot open clinics to diagnose the disease and prescribe the medicines.

PCI has clarified that there is no provision in the Pharmacy Practice Regulations (PPR), 2015 which allows the pharmacists to practice medicine. Under the said Regulations, the registered pharmacist is required to dispense medicines on the prescription of a registered medical practitioner and can counsel the patient or care giver on medicine to enhance or optimise drug therapy.

The elements of patient counselling includes, name and description of the drugs;the dosage form, dose, route of administration, and duration of drug therapy; intended use of the drug and expected action; special directions and precautions for the drug; common severe side effects or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur; techniques for self monitoring drug therapy; proper storage of the drugs; prescription refill information; action to be taken in the event of a missed dose and to ensure rational use of drugs.

Dr. B Suresh, president of PCI informed that there are few groups of pharmacists who are claiming that they are doctors and there are various messages being circulated on social media, e-mails, WhatsApp etc. that pharmacists are empowered under PPR, 2015 to open pharma clinics to diagnose the disease and prescribe medicines.

We would like to clarify that there are no such provision under PPR, 2015 which allows pharmacists to diagnose and prescribe medicine. PPR, 2015 only allows the pharmacists to practice pharmacy and not medicine, they can counsel the patient or care giver and dispense medicines on the prescription of a registered medical practitioner but cannot prescribe medicines to the patients

He further adds, “Under no circumstances, the registered pharmacist is empowered under the Pharmacy Act, 1948 and PPR, 2015 to practice medicines or open clinics to provide medical care.

BUT, My query is : Can a registered pharmacist(PHARM D) approved with Clinical Pharmacy Council give PHARMA CARE in his PHARMACY? Services like prior authorization and refill authorization for prescription drugs is permitted?

5 Famous Pharmacists to Inspire You

5 Famous Pharmacists to Inspire You

• 1) Alexander Flemming. Contribution: The discovery of penicillin. ...
• 3) John Pemberton. Contribution: Created Coca-Cola. ...
• 4) Hubert Humphrey. Contribution: USA Vice President (1965 – 1968) ...
• 5) Friedrich Serturner. Contribution: Discovered Morphine.

Doctors surgical strikes

Patient Satisfaction In Healthcare

Days are over when a patient walking inside a hospital only care about the doctor giving him right treatment for his diseases. 

Today's patient is our consumer who unlike any other service industry now expect the same type of customer delight from a hospital in addition to the treatment.

He wants the full value for his money, in terms of having a good doctor, friendly hospital staff, hospital ambiance, his comforts etc. 

They judge the hospital on various parameters other than doctor and there view about the hospital can make or break the hospital image. 

But why all of a sudden the whole industry is more worried about patient satisfaction ??? 

The reason is simple : One happy customer will get 2 more customer, but one unhappy customer will cost 10 other customers. 

But what exactly do patients want, besides having their conditions treated???

According to a survey, patients valued the interpersonal skills of their doctors as much as if not more than their technical skills.

So how exactly can we ensure that the patients are satisfied ??? 

This can be a tricky question, the reason being that no two person think alike, I might feel annoyed if a Patient Relation executive keep asking me the details to fill form and try to understand my socio-economic status n all , but on other hand you might think that as a patient care from his side to understand what exactly is the requirement of the patient. 

So aiming a 100% patient satisfaction is not a practical target to achieve , but all the organisation should try to achieve the maximum which they are capable of. 

A very easy method of ensuring patient satisfaction is  SATISFIED & MOTIVATED STAFF, when your staff is happy with the management and are motivated towards work then be assured that 70% of your work is done. Programs need to be in place to help physicians and nurses improve their bedside manners. Secondly, staff and providers need to be fully engaged, and communication is the key here. Patients would like to be acknowledged; simply greeting them as you enter their room sets the right tone for rest of your interaction with them. Next, introduce yourself. Give them your name and your specialty. This is then followed by explaining to them, step by step, in accessible language, what is going to happen and how the procedure is going to last. Finally, spend sometime answering their questions, and thank the patient before leaving their room.

It would seem like patient satisfaction is intricately linked to patient outcomes. Patients who are more satisfied are more likely to adhere to treatment plans and maintain their relationships with their healthcare providers. This essentially translates to lower readmission rates, reduced lengths of stay, and increased savings for the hospitals.

What exactly is patient satisfaction:

Many hospitals think patient satisfaction is all about keeping patients happy; they are missing the point, because patient satisfaction should also be about a hospital’s philosophy about delivery of care, and that involve the complete team of hospital from front office , doctors, nurses, billing, diagnostics, housekeeping etc.

Unfortunately, doctors spend more time improving their medical knowledge than improving their approach to patient care.

What does a hospital achieve from Patient Satisfaction :

• Greater profitability.
• Improved patient retention and patient loyalty.
• Increased patient referrals.
• Improved compliance.
• Improved productivity.
• Better staff morale.
• Reduced staff turnover.
• Improved collections.
• Greater efficiency.
• Reduced risk of malpractice suit.
• Personal and professional fulfillment.
• Name and fame to the organisation

So to sum up all the above things we can just say that A Happy Patient is Key for Success for the Hospital.

There are simple solutions to improve patient satisfaction scores. All a practice needs to do is to listen and take heed of what their patients have to say.

• 
  
• 
  

Pharmaceutical Policy

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs (both brand name and generic), biologics (products derived from living sources, as opposed to chemical compositions), vaccines and natural health products. Pharmaceutical policy includes:

Funding of Research in the Life Sciences

In many countries, an agency of the national government (in the U.S. the NIH, in the U.K. the MRC, and in India the DST) funds university researchers to study the causes of disease, which in some cases leads to the development of discoveries which can be transferred to pharmaceutical companies and biotechnology companies as a basis for drug development. By setting its budget, its research priorities and making decisions about which researchers to fund, there can be a significant impact on the rate of new drug development and on the disease areas in which new drugs are developed. For example, a major investment by the NIH into research on HIV in the 1980s certainly could be viewed as an important foundation for the many antiviral drugs that have subsequently been developed.

Patent Law

While patent laws are written to apply to all inventions, whether mechanical, pharmaceutical, or electronic, the interpretations of patent law made by government patent granting agencies (the United States Patent and Trademark Office, for example) and courts, can be very subject-matter specific with significant impact on the incentives for drug development and the availability of lower-priced generic drugs. For example, a recent decision by the United States Court of Appeals for the Federal Circuit in Pfizer v. Apotex, 480 F.3d 1348 (Fed.Cir.2007), held invalid a patent on the “pharmaceutical salt” formulation of a previously patented active ingredient. If that decision is not overturned by the United States Supreme Court, generic versions of the drug in controversy, Norvasc (amlodipine besylate) will be available much earlier. If the reasoning of the Federal Circuit in the case is applied more generally to other patents on pharmaceutical formulations, it would have a significant impact in speeding generic drug availability (and, conversely, some negative impact on the incentives and funding for the research and development of new drugs).

Licensing

This involves the approval of a product for sale in a jurisdiction. Typically a national agency such as the US Food and Drug Administration (specifically, the Center for Drug Evaluation and Research, or CDER), the UK Medicines and Healthcare Products Regulatory Agency or Health Canada or Ukrainian Drug Registration Agency [1] is responsible for reviewing a product and approving it for sale. The regulatory process typically focuses on quality, safety and efficacy. To be approved for sale a product must demonstrate that it is generally safe (or has a favourable risk/benefit profile relative to the condition it is intended to treat), that it does what the manufacturer claims and that it is produced to high standards. Internal staff and expert advisory committees review products. Once approved, a product is given an approval letter or issued with a notice of compliance, indicating that it may now be sold in the jurisdiction. In some cases, such approvals may have conditions attached, requiring, for example additional ‘post-marketing’ trials to clarify an issue (such as efficacy in certain patient populations or interactions with other products) or criteria limiting the product to certain uses.

Pricing

In many jurisdictions drug prices are regulated. For example, in the UK the Pharmaceutical Price Regulation Scheme is intended to ensure that the National Health Service is able to purchase drugs at “reasonable prices.” In Canada, the Patented Medicine Prices Review Board examines drug pricing, compares the proposed Canadian price to that of seven other countries and determines if a price is “excessive” or not. In these circumstances, drug manufacturers must submit a proposed price to the appropriate regulatory agency.

Reimbursement

Once a regulatory agency has determined the clinical benefit and safety of a product and pricing has been confirmed (if necessary), a drug manufacturer will typically submit it for evaluation by a payer of some sort. Payers may be private insurance plans, governments (through the provision of benefits plans to insured populations or specialized entities likeCancer Care Ontario, which funds in-hospital oncology drugs) or health care organizations such as hospitals. At this point the critical issue is cost-effectiveness. This is where the discipline of pharmaco-economics is often applied. This is a specialized field of health economics that looks at the cost/benefit of a product in terms of quality of life, alternative treatments (drug and non-drug) and cost reduction or avoidance in other parts of the health care system (for example, a drug may reduce the need for a surgical intervention, thereby saving money). Structures like the UK’s National Institute for Health and Clinical Excellence and Canada’s Common Drug Review evaluate products in this way. Some jurisdictions do not, however, evaluate products for cost-effectiveness. In some instances, individual drug benefit plans (or their administrators) may also evaluate products. Additionally, hospitals may have their own review committees (often called a Pharmacy and Therapeutics (P&T) committee) to make decisions about which drugs to fund from the hospital budget.

Drug plan administrators may also apply their own pricing rules outside of that set by national pricing agencies. For example, British Columbia uses a pricing model calledreference-based pricing to set the price of drugs in certain classes. Many US pharmacy benefit managers (PBMs) use strategies like tiered formularies and preferred listings to encourage competition and downward pricing pressure, resulting in lower prices for benefits plans. Competitive procurement of this sort is common among large purchasers such as the US Veteran’s Health Administration.

Typically, a manufacturer will provide an estimate of the projected use of a drug as well as the expected fiscal impact on a drug plan’s budget. If necessary, a drug plan may negotiate a risk-sharing agreement to mitigate the potential for an unexpectedly large budget impact due to incorrect assumptions and projections.

Because the clinical trials used to generate information to support drug licensing are limited in scope and duration, drug plans may request ongoing post-market trials (often called Phase IV or pragmatic clinical trials) to demonstrate a product’s ‘real world safety and effectiveness.’ These may take the form of a patient registry or other means of data collection and analysis.

Once a product is deemed cost-effective, a price negotiated (or applied in the case of a pricing model) and any risk-sharing agreement negotiated, the drug is placed on a drug list or formulary. Prescribers may choose drugs on the list for their patients, subject to any conditions or patient criteria.

Formulary management

At the core of most reimbursement regimes is the drug list, or formulary. Managing this list can involve many different approaches. Negative lists – products that are not reimbursed under any circumstances are used in some jurisdictions (c.f. Germany). More dynamic formularies may have graduated listings such as Ontario’s recent conditional listing model. As mentioned, formularies may be used to drive choice to lower cost drugs by structuring a sliding scale of co-payments favouring cheaper products or those for which there is a preferential agreement with the manufacturer. This is the principle underlying preferred drug lists used in many US state Medicaid programs. Some jurisdictions and plans (such as Italy) may also categorize drugs according to their ‘essentialness’ and determine the level of reimbursement the plan will provide and the portion that the patient is expected to pay.

Formularies may also segment drugs into categories for which a prior authorization is needed. This is usually done to limit the use of a high cost drug or one that has potential for inappropriate use (sometimes called ‘off-label’ as it involves using a product to treat conditions other than those for which its license was granted). In this circumstance a health care provider would have to seek permission to prescribe the product or the pharmacist would have to obtain permission prior to dispensing it.

Eligibility

Depending on the structure of the health care system, drugs may be purchased by patients themselves, a health care organization on behalf of patients or an insurance plan (public or private). Hospitals typically limit eligibility to their in-patients. Private plans may be employer-sponsored such as Blue Cross, mandated by legislation, as in Quebec or consist of an outsourcing arrangement for a public plan, such as the US Medicare Part D scheme. Public plans may be structured in a variety of ways including:

1. Universal, as in Australia’s Pharmaceutical Benefits Scheme
2. Restricted by age, as in the Ontario Drug Benefit Plan for seniors
3. Segmented by disease group, such as Manitoba’s cystic fibrosis drug plan
4. Geared to income, such as US Medicaid programs in many states

Additionally, plans may be structured to respond to the ‘catastrophic’ impact of drug expenses incurred by those with serious diseases or high drug spending relative to income. These patient populations, often called ‘medically needy,’ may have all or part of their drug costs covered by ‘plans of last resort,’ (typically government-sponsored). One such plan is Ontario’s Trillium Drug Program.

Pharmaceutical policy may also be used to respond to health crises. For example, Argentina launched REMEDIAR during its financial crisis of 2002. The government-sponsored program provides a specified list of essential drugs to primary care clinics in low-income neighbourhoods. Similarly, Brazil provides drugs for HIV/AIDS free to all citizens as a deliberate public health policy choice.

Eligibility policy also focuses on cost-sharing between a plan and the beneficiary (the insured person). Co-payments may be used to drive certain prescribing choices (for example, favouring generic over brand drugs or preferred over non-preferred products). Deductibles may be used as part of geared to income plans.

Prescribing

Pharmaceutical policy may also attempt to shape and inform prescribing. Prescribing may be limited to physicians or include certain classes of health care providers such as nurse practitioners and pharmacists. There may be limitations placed on each class of provider. This may take the form of prescribing criteria for a drug, limiting its prescribing to a particular type of specialist physician for example (such as HIV/AIDS drugs to physicians with advanced training in this area), or it may involve special drug lists that a specific type of health care provider (such as a nurse practitioner) may prescribe from.

Plans may also seek to influence prescribing by providing information to prescribers. This practice is often called ‘academic detailing’ to differentiate it from the detailing (provision of drug information) done by pharmaceutical companies. Organizations such as Australia’s National Prescribing Service typify this technique, providing independent information, including head-to-head comparisons and cost-effectiveness information to prescribers to influence their choices.

Additionally, efforts to promote the ‘appropriate use’ of medications may also involve other providers like pharmacists providing clinical consulting services. In settings such as hospitals and long-term care, pharmacists often collaborate closely with physicians to ensure optimal prescribing choices are made. In some jurisdictions, such as Australia, pharmacists are compensated for providing medication reviews for patients outside of acute or long-term care settings. Pharmacist collaboration with family physicians in order to improve prescribing may also be funded.

Pharmacy services

Pharmaceutical policy may also encompass how drugs are provided to beneficiaries. This includes the mechanics of drug distribution and dispensing as well as the funding of such services. For example, some HMOs in the US use a ‘central fill’ approach where all prescriptions are packaged and shipped from a central location instead of at a community pharmacy. In other jurisdictions, retail pharmacies are compensated for dispensing drugs to eligible beneficiaries. A state-operated approach may also be taken, as with Sweden’s Apoteket, which had the monopoly on retail pharmacy until 2009, and was not-for-profit. Pharmaceutical policy may also subsidize smaller, more marginal pharmacies, using the rationale that they are needed health care providers. The UK’s Essential Small Pharmacies Scheme works this way.

medication error

Posted by Dpharmdindia on Wednesday, February 17, 2016

medication-errors

The State of Affairs of Medical Profession - Pathetic

The State of Affairs of Medical Profession & Pharmacy Profession - Pathetic 

1. When a kid is selected for MBBS he/she is darling of everybody, but the moment one clears MBBS/Pharm D the whole attitude of society changes. You are supposed to have the maturity of a man in the forties. 2 The doctor is supposed to only serve and not to receive. Whatever you charge as professional fees is considered a penal amount by the patients. 3. In case the person has the slightest acquaintance with the doctor, you are not supposed to charge him/her.......or else you are labelled as money minded 4. The doctor is expected to be available round the clock and treat the patient despite his/her personal commitments. 5. Whatever the condition of the patient, however much he disregards your advice, the patient MUST be cured; otherwise you are alleged to be negligent. 6. Any Tom, Dick and Harry can threaten, abuse, misbehave or damage property of hospital/clinic with impunity without any fear of law as patient is always the aggrieved party. 7. If any Lab investigation is advised and it comes out to be normal, instead of patient being happy it is alleged that doctor is getting unnecessary investigations done for ulterior motives. 8 If investigation is not advised and some mishap occurs the doctor is hauled in the court of law for being negligent. So again it is Damned if you do, damned if you dont 9. If any tragedy occurs it is highlighted in media with catchy captions to ruin the reputation of the doctor without verifying the facts. 10. All RMPs and unregistered practitioners, NEEM-HAKEEM, lab technicians and even medical shop salesmen are allowed to practice medicine! The worse part is that the illiterate and even literate people of India treat all of these people like doctors. 11 Only doctors are forced to work in rural and government hospitals (without any facilities) to get the degree. In no other profession this is mandatory. No lawyer is ever asked to work in Gram Panchayats, no engineer is asked to work in various rural projects of the government. The government wants that doctors should not work and settle in foreign countries but there is no such demand and no restrictions on IIM/IIT graduates. 12 As per NCHRC Bill, for a doctor doing any occupation other than medicine is misconduct. Why single out us? Are we not the free citizens of India? Even so called busy politicians are doing practice in court and involved in lot many businesses. 13. Clinical Establishment Act gives power to District authorities (without any knowledge of medicine) to impose fine up to Rs 5 lakh and even closure of clinic. There is no such law for any other profession. 14. Medical profession is recognized as a business by law, so the doctors are sued in consumer courts . We dont get space for clinics/ hospitals at subsidized rates, rather we are charged more. We give electricity bill, house tax etc on commercial rates. Yet we are not supposed to be commercial. 15. We have to deal with many govt agencies, face harassment from them as they consider that doctors are the softest target, e.g. Development authorities, Municipal authorities, Fire department, Labour department, Income tax, Pollution department, to name a few. 16. We invest the maximum time; 6 years to get the basic qualification, 3 more years for specialisation and further 3 yrs for super specialization. On an average a superspecialist invests aprox. 12-14 yrs for the medical study only . Compared with any profession, this is 3 to 8 years more; also compare the money that we get at that time with other professions. 17 We work under maximum mental tension as we are accountable, have emotional attachment with our patients, work for long and even odd hours, working even when we are not well. The threat of violence and litigation looms around us all the time and even harassment by Govt. agencies is routine. The double standards on the part of Society in general and government in particular defy all logic. On the one hand they charge us everything at maximum commercial rate, impose different. http://www.doctorshangout.com/forum/topics/the-state-of-affairs-of-medical-profession

Pharma Clinic- Now PHARMACISTS can also Practice like Physicians within their own Clinical Setups........ but Pharmacists cannot open clinics to diagnose disease & prescribe medicine; clarifies PCI

फार्मासिस्ट जो प्रैक्टिस कर रहे हैँ या करना चाहते हैँ जाने कुछ रुल जो ppr 2015 का गजट फार्मेसी कौंसिल ऑफ इंडिया से जारी होने के बाद प्रभावी हो गए ह

Pharma clinic means Pharmacists can treatment only as a primary health care / schedule k OTC medicine priscribe/treatment of uncomplicated disease .jiske liye koi registration Ki jarurat nahi hoti. Local district ke CMHO ko jab clinic estblisment aa jaye to registered karva skate hai.any pharacists can open pharma clinic.but can not stock medicine without drug licence.

If pharmacists can do as such type of work in pharmacy .separate cell must estblised in pharmacy as a primary care with drug councilling chamber.
Drug can dispence by pharmacists supervision/ presence so there no problems create for pharmacists . But all medicine bill should be signed & inspected by pharmacists.

Now PHARMACISTS can also Practice like Physicians . . . . .within their own Clinical Setups

GOOD PHARMACY NEWS

Advanced Pharmacy Practice Model came to India , introduced by CLINICAL PHARMACY COUNCIL.

- PHARMA CLINIC - A Center of Pharmaceutical Health Care. . . .

Pharma Clinic practice model framed by CLINICAL PHARMACY COUNCIL within certain provisions of PPR-2015 of Pharmacy Act 1948 framed by PHARMACY COUNCIL OF INDIA.

Its a clinical setup outside the hospitals , where qualified registered Pharmacists provides their professional services on individual consultation of patients. within /along with Pharma Clinic Pharmacists also facilitate Drug Dispensing services by getting a Retail Drug license from local drugs regulatory authority.

Practice Pharmacy in your Own Clinical setup on individual patients consultations , collect fees fro professional services. Use sign board with your names and qualifications on the board.

These are all lawful as per Pharmacy Practice Regulations -2015 (PPR-2015) of Pharmacy Act 1948 framed by Pharmacy Council of India.

Now, Pharmacists also can practice as like doctors within their own clinical setups on patients consultations.

As per Sec 2 (I) (II) (III) of Chapter 2 of PPR-2015 A registered pharmacist is eligible to practice pharmacy, pharmacy practice means not only Compound, Labelling and Dispensing of Drugs. Pharmacists also provide the following professional services

- Participation in Drug & Device selection - Administration of Drugs through different routes of administration i.e IM , IV, IVF, SC , PO etc. . . - Drug Regimen VV Reviews - Drug Research - Patient Counselling - Pharmaceutical Care in all specialties like cardiology, Dermatology , Oncology, etc. . . including Primary Care

Pharmaceutical Care is a bunch of 1000's professional services of Pharmacy Practices , for detailed services prescribed by PHARMACY COUNCIL OF INDIA refer Appendix III of PPR-2015 of Pharmacy Act 1948. F As per Sec 2 (g) of PPR-2015 Pharmaceutical Care means - along with patients care a pharmacist can prevent disease or and eliminate disease or and reduction of symptoms ( symptomatic treatment to all uncomplicated diseases ) arresting or slowing of disease process.

As per Sec 2 (h) (iv) of PPR-2015 Clinical Pharmacists may provide care in all health care settings ( Community Pharmacy /Hospitals / Clinics / Nursing Homes / Own Health care or Clinical setups like PHARMA CLINICS .

As per sec 3.3 (b) of Chapter 1 of PPR-2015 A registered pharmacist may display his/her name on sign board along with educational qualifications and PCI registration number.

As per Sec 3.3 (c) of Chapter 2 of PPR -2015 A Registered Pharmacist may use /display suffix any professional degrees , certifications , memberships and honors

CPC registered pharmacists may prefix RCPH and etc. . . specialty certification to their names on sign boards of practice areas or setups.

As per Sec 6.5 of Chapter 2 of PPR-2015 A registered pharmacist may charge / collect fees for their professional services on individual consultations.

As per Sec 11.2 of Chapter 6 of PPR-2015 A registered pharmacist may participate him/herself in public health programs , responsible for prevention and care of epedimic & communicable diseases

As per Sec 13 (s) of PPR-2015 of Pharmacy Act 1948 A registered pharmacist should not claim himself/herself as a specialist. means may claimed on certification of any professional organization in certain specialty .

CPC certified specialist registered pharmacists may prefix these specialty certifications to their names on sign board of any professional practice premises ( including PHARMA CLINIC setup)

Not need to get any approval / permission / NOC from any CMO or DM& HO to establish any setup of Pharmacy Practice ( including PHARMA CLINIC ), But Only for retail sale of drugs you required to get license from local drugs regulatory authority.

If the act ( CLINICAL ESTABLISHMENTS Act 2010 ( Regulations & Registrations ) applicable to pharmacy establishments in any state - the state belonging regd pharmacists may required to register the pharmacy establishment (pharma clinic) under this act with concer

"Public Pharmacist medicine " es AWARENESS campain ko suru karna chahiye pure desh me pharmacist ka naam sabhi ko yaad ho jaye aur naam yaad aate hi pharmacist ka role and importance mind me aaye aur dil me respect.....इसकी जरूरत ज्यादा है की pharmacists इन नियमो खुद ऐसे pharmacy store खोल धरातल पर लागु करे वरना नियम के नाम पर हम खुद को ज्यादा दिन तक नही ढो सकते और लोगो को ये नियम भी फालतू का लगने लगेगा मतलव हम फार्मासिस्ट फालतू के लगने लगेगे

फार्मासिस्ट स्वास्थ्य सेवाओं की महत्वपूर्ण कड़ी है इसलिए वह स्वास्थ्य सेवाओं की सभी सेवाओं का उपयोग कर सकता है
Pharmacists can diagnose disease, treatment ,priscriber medicine ,drug councilling of patient ,stock & dispense medicine ,
सच्चाई यही है
फार्मासिस्ट रोगी की सेवा के लिए कुछ भी कर सकता है परिस्थिति अनुसार यूज करेँ अपने अधिकार फार्मासिस्ट

pharmacist practice regulation 2015 - Google Search -https://www.google.co.in/search…

ELIGIBILITY to Practice PHARMA CLINIC

Pharmacists, who are willing to practice Clinical Pharmacy outside the Hospital setups and within their own Clinical setup PHARMA CLINIC, they should meet the following eligibility criteria:

1. Applicant Pharmacist should be a Licensed/Registered Pharmacist by any state Pharmacy Council of India.

2. Applicant Pharmacist should be a Registered Clinical Pharmacist (RCPh) in Clinical Pharmacy Council (CPC).

3. a. Applicant Pharmacist should be have minimum 3 months experience as a Hospital /or/ Clinical Pharmacist under supervision of MCI Registered Physician of any Hospital.

[OR]

b. Applicant Pharmacist should complete 2 months SAT-CP Training Program in CPC.

राजस्थान के फार्मासिस्ट के लिए CPC ट्रेनिंग जरुरी है क्योंकि उनकी ट्रेनिंग फार्मेसी स्टोर मेँ होती है हॉस्पिटल मेँ नही

HOW TO APPLY

Step 1: If you are not a RCPh in CPC, Register your name as Clinical Pharmacist in CPC with Application FORM-1.

One time Registration Fee: Rs 2600/- only.

Step 2: After Confirmation of Registration in CPC, Apply for Clinical Pharmacy Specialty Certification to BCPS in CPC. For General Practice apply for Consultant Clinical Pharmacist (CCP) certification by submitting your previous or current Experience Certificate [or] SAT-CP Training certificate.

Who are not having Previous Experience Apply for SAT-CP Training Program with Application FORM-2B

For CCP certification apply with Application FORM-2

(NOTE: For any other Specialty Clinical Pharmacy Practice apply for Specialty Certification to BCPS) For Specialty certification apply with Application FORM-3

Step 3: After confirmation of successful Certification, Apply for PHARMA CLINIC approval with Application FORM-4

Step 4: ENJOY YOUR PRACTICE BY SERVING THE MANKIND.

PHARMA CLINICS are Community Health Care setups outside the hospitals and medical homes, where qualified and registered / licensed Pharmacists provide Clinical Pharmacy services to the patients on their individual consultations.

PHARMA CLINICS are Community Health Care setups outside the hospitals and medical homes, where qualified and registered / licensed Pharmacists providesClinical Pharmacy services to the patients on their individual consultations.

A newest pharmacy practice model in India.

To become Clinical Pharmacy Practitioner Member (CPPM) of Clinical Pharmacy Council, register your name by applying in an on-line application. Transform from Tradtional Pharmacy Practice into Advanced Clinical Pharmacy Practice to provide better healthcare to the nation. 

Clinical Pharmacy Council (CPC) with the objective to Promote, Support, Strengthen, and Develop the Clinical Pharmacists through Membership Registration and Decolonising throughout India.

Pharmacy profession comprising the Hospital and Clinical pharmacy sectors is under going rapid change in India. Clinical Pharmacy Practice sector need skilled Pharmacy professionals, who can face global challenges and compete with multinationals. The Pharmacist is no longer a mere dispenser of drugs. But has assumed a more Clinical role in Therapeutic Drug, Disease Monitoring and Management and as overall Health Care Provider.

We realized that to Strengthen and Upgrade the Clinical Pharmacy Education and Practice in India, need to competent Clinical Pharmacists Force, which is able to meet the growing demands of the Health Care in India.

Today, a need has been felt on the Imperative for transparency, accountability and accessibility in order to establish Public and Physicians trust in Clinical Pharmacists and their Services in India. This would be feasible only if all Clinical Pharmacists are associated on a single stage.

CPC Membership Registration of Clinical Pharmacists will ensure Transparency, Accountability, and Accessibility in Clinical Pharmacy Services. By disclosing all Results or / and Interventions of Clinical Pharmacy Practice, Public confidence in Clinical Pharmacists in likely to be enhanced.

 As a step towards the directions, Clinical Pharmacy Council (CPC)  to Recognize Indian Clinical Pharmacists by the Process of Membership Registration and so as to strengthen & upgrade the Clinical Pharmacy Practice in India.

SAT-CCP course is a 6 months duration home based ( DISTANCE ) ContinuousPharmacy Education & Professional Development credential (value added) program. 

SAT-CCP course was aimed to educate, train, and advance Traditional PharmacyPractitioners ( Dispensing Pharmacists ) in providing advanced Clinical Pharmacyservices so as to deliver better health care to the nation.

SAT-CCP course improves professional expertise in the field of Clinical Pharmacy and prepares most competent Clinical Pharmacists force to the nation with world class standards.

SAT-CCP course was structured as three different sessions of self Study, Assessment, and Training in the field of Clinical Pharmacy. After successful completion of all sessions of the course the candidates has to appear a qualifying examination.

SAT - CCP (Self Assessment, Training & Certificate program in Clinical Pharmacy) is a Continuous Professional Developement Program in Clinical Pharmacy.  It's a 6 months duration home based distance learning program.

SAT-CCP course is a 6 months duration home based ( DISTANCE ) ContinuousPharmacy Education & Professional Development credential (value added) program. 

SAT-CCP course was aimed to educate, train, and advance Traditional PharmacyPractitioners ( Dispensing Pharmacists ) in providing advanced Clinical Pharmacyservices so as to deliver better health care to the nation.

SAT-CCP course improves professional expertise in the field of Clinical Pharmacy and prepares most competent Clinical Pharmacists force to the nation with world class standards.

SAT-CCP course was structured as three different sessions of self Study, Assessment, and Training in the field of Clinical Pharmacy. After successful completion of all sessions of the course the candidates has to appear a qualifying examination. 

There are two modes qualifying examination:

SAT-CCP course is a 6 months duration home based ( DISTANCE ) ContinuousPharmacy Education & Professional Development credential (value added) program. 

SAT-CCP course was aimed to educate, train, and advance Traditional PharmacyPractitioners ( Dispensing Pharmacists ) in providing advanced Clinical Pharmacyservices so as to deliver better health care to the nation.

SAT-CCP course improves professional expertise in the field of Clinical Pharmacy and prepares most competent Clinical Pharmacists force to the nation with world class standards.

SAT-CCP course was structured as three different sessions of self Study, Assessment, and Training in the field of Clinical Pharmacy. After successful completion of all sessions of the course the candidates has to appear a qualifying examination. There are two modes qualifying examination:

1. Online (Computer Based Online Examination)
2. Offline  (Pen & Paper Based Examination)

The mode of selection of the qualifying examination is the choice of the candidate; they have to select any one mode of examination at the time of the enrollment and may change at any time during the course period and just before 7 days of the examination.  

COURSE DURATION: 6 Months

FREQUENCY OF COURSE:  Admissions are open throughout a year. Applicants are requested to submit application before 25th of the Month, so that program will be starts from 1st of the next Month.

Clinical Pharmacy Council (CPC) is an autonomous Professional Organization that promotes, supports, implements and advances education, practice and research in clinical pharmacy. CPC represents clinical pharmacists and others who are interested in clinical pharmacy and in the development of clinical pharmacy throughout India.

Clinical Pharmacy Council works in non profit motive for the prime objective of - The development, promotion and advancement of Clinical Pharmacy Education and Practice in India.

The CPC actively develops and promotes Clinical Pharmacy Education and Practice as well as develops individual Clinical Pharmacy Practitioners through Professional Curricula, Professional Recognition, Credentialization, Professional tools, frameworks, support and contributes by promoting Advanced Practice of CLINICAL PHARMACY in India.

The CPC is able to access a wide range of Knowledge and Expertise in Clinical Pharmacy to enable high quality patient care in India.

CLINICAL PHARMACY COUNCIL provides certain fellowships (FCPC and FRCPC) annually to the eligible candidates.

CLINICAL PHARMACY COUNCIL provides certain awards annually to the eligible candidates through the nomination process

 In India hundreds of pharmacists providing their professional services in certain health care specialties as clinical pharmacy specialists, across the world there is huge demand for Clinical Pharmacy Specialists, Some professional organization providing them professional recognition through certain Specialty Certification Programs.

For MBBS  - ALLOPATHY CLINICS,

For BAMS - AYURVEDIC CLINICS,

For BHMS - HOMEO CLINICS,

For BNYS - YOGA CLINICS,

For BUMS - UNANI CLINICS,

For BVSc - VET CLINICS,

For BDS - DENTAL CLINICS,

Even for BPT - PHYSIO CLINICS are there in India.

www.clinicalpharmacy.in/pharma-clini

Pharmacists cannot open clinics to diagnose disease & prescribe medicine; clarifies PCI

Swati Rana, Mumbai Wednesday, October 21, 2015, 08:00 Hrs  [IST]

Clearing the doubts on pharmacists can open pharma clinics to treat common disease and prescribe medicine, Pharmacy Council of India (PCI) has recently notified that the pharmacists cannot open clinics to diagnose the disease and prescribe the medicines. PCI has clarified that there is no provision in the Pharmacy Practice Regulations (PPR), 2015 which allows the pharmacists to practice medicine. Under the said Regulations, the registered pharmacist is required to dispense medicines on the prescription of a registered medical practitioner and can counsel the patient or care giver on medicine to enhance or optimise drug therapy. The elements of patient counselling includes, name and description of the drugs;the dosage form, dose, route of administration, and duration of drug therapy; intended use of the drug and expected action; special directions and precautions for the drug; common severe side effects or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur; techniques for self monitoring drug therapy; proper storage of the drugs; prescription refill information; action to be taken in the event of a missed dose and to ensure rational use of drugs. Dr. B Suresh, president of PCI informed that there are few groups of pharmacists who are claiming that they are doctors and there are various messages being circulated on social media, e-mails, WhatsApp etc. that pharmacists are empowered under PPR, 2015 to open pharma clinics to diagnose the disease and prescribe medicines. We would like to clarify that there are no such provision under PPR, 2015 which allows pharmacists to diagnose and prescribe medicine. PPR, 2015 only allows the pharmacists to practice pharmacy and not medicine, they can counsel the patient or care giver and dispense medicines on the prescription of a registered medical practitioner but cannot prescribe medicines to the patients He further adds, “Under no circumstances, the registered pharmacist is empowered under the Pharmacy Act, 1948 and PPR, 2015 to practice medicines or open clinics to provide medical care.” BUT, My query is : Can a registered pharmacist and pharmacotherapist (PHARM D) approved with Clinical Pharmacy Council give PHARMA CARE in his PHARMACY? Services like prior authorization and refill authorization for prescription drugs is permitted?